based on 5 analysts
100.00%
Buy
0.00%
Hold
0.00%
Sell
Based on 5 analysts offering long term price targets for Medplus Health Services Ltd. An average target of ₹918
Source: S&P Global Market Intelligence
Medplus Health Services Ltd price forecast by 5 analysts
Upside of24.26%
High
₹1100
Target
₹918.00
Low
₹830
Medplus Health Services Ltd target price ₹918, a slight upside of 24.26% compared to current price of ₹735.6. According to 5 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Medplus Health Services Ltd revenue growth forecast
Expected growth rate Q1, FY2026:33.38%
Forecast
Actual
Including amortisation and stock based compensations
Medplus Health Services Ltd EPS growth forecast
EPS estimate Q1, FY2026:194.16%
Forecast
Actual
Source: S&P Global Market Intelligence
Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | + 7.82 % |
3 Month Return | + 16.43 % |
1 Year Return | -11.68 % |
Market Stats | |
Previous Close | ₹738.80 |
Open | ₹734.10 |
Volume | 3.91L |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹8,832.14Cr |
P/E Ratio | 87.95 |
PEG Ratio | 25.13 |
Market Cap | ₹8,832.14 Cr |
P/B Ratio | 7.03 |
EPS | 5.49 |
Dividend Yield | 0 |
Sector | Retail |
ROE | 0.75 |
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
BUY | ₹8,832.14 Cr | -6.82% | 0.54 | ₹65 Cr | ₹5,624 Cr | |
BUY | ₹6,179.05 Cr | -2.59% | 0.50 | ₹19 Cr | ₹489 Cr | |
NA | ₹626.67 Cr | 111.12% | 0.50 | NA | NA | |
NA | ₹422.94 Cr | 124.76% | 0.86 | ₹4 Cr | ₹541 Cr | |
NA | ₹11,166.02 Cr | 12.72% | 0.72 | ₹176 Cr | ₹1,842 Cr |
Organisation | Medplus Health Services Ltd |
Headquarters | |
Industry | Retail |
E-voting on shares | Click here to vote |
Key events for Medplus Health Services Ltd
Medplus Health anticipates steady growth in private label medicines. The share price increased by 3% following stake acquisitions by Kotak and other funds.
Medplus Health Shares Surge on Strong Performance - 18 Nov, 2024
Medplus Health Services saw a 3% rise in shares following a strong Q2 report, with net profit doubling. Kotak Small Cap Fund also acquired a stake amid significant fund activity.
MedPlus Targets Profitability Through Private Labels - 15 Nov, 2024
MedPlus Health Services Ltd aims to increase EBITDA by at least 1.2% over the next 6-8 quarters, driven by a 3.5% rise in revenue from private label products. Overall revenue grew nearly 12% to Rs 1,576.2 crore compared to the previous year.
Medplus Health Reports Strong Q2 Growth - 14 Nov, 2024
Medplus Health Services announced impressive Q2 2024 results, with revenue up 11.9% and profit soaring 165.97% year-over-year. Analysts recommend a Strong Buy, reflecting optimism despite mixed stock performance.
Medplus Health Reports Strong Q2 Earnings Growth - 13 Nov, 2024
Medplus Health Services experienced a significant profit increase in Q2 FY25, with net profit rising to Rs 38.74 crore, a 165.97% increase. Revenue also grew by 11.9% to Rs 1,576.17 crore. The company plans to expand by opening 600 new stores in tier-2 cities over the next three years.
MedPlus Health Reports Strong Q2 Profit Growth - 12 Nov, 2024
MedPlus Health's Q2 net profit more than doubled to Rs 38.74 crore, driven by strong OTC medicine demand. Revenue rose 12% to Rs 1,576 crore, with plans to open 600 new stores in tier-2 cities over three years.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Profit Spike
Netprofit is up for the last 2 quarters, 14.36 Cr → 38.74 Cr (in ₹), with an average increase of 62.9% per quarter
Price Rise
In the last 7 days, MEDPLUS stock has moved up by 4.9%
MF Holding Up
Mutual Funds have increased holdings from 12.25% to 18.08% in Sep 2024 quarter
Revenue Rich
Revenue is up for the last 2 quarters, 1.49K Cr → 1.58K Cr (in ₹), with an average increase of 5.7% per quarter
Against Peers
In the last 1 year, Muller & Phipps India Ltd has given 179.7% return, outperforming this stock by 191.4%
Promoter Holding Unchanged
Promoters holdings remained unchanged at 40.39% of holdings in Sep 2024 quarter
FII Holding Down
Foreign Institutions have decreased holdings from 14.85% to 14.72% in Sep 2024 quarter
Retail Holding Down
Retail Investor have decreased holdings from 22.52% to 16.85% in Sep 2024 quarter
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 40.39% | 0.00 | |
Foreign Institutions | 14.72% | ||
Mutual Funds | 18.08% | 47.60 | |
Retail Investors | 16.85% | ||
Others | 9.96% |
Medplus Health Services Ltd in the last 5 years
Lowest (76.04x)
October 30, 2024
Industry (-287.71x)
November 19, 2024
Today (87.95x)
November 19, 2024
Highest (263.63x)
March 17, 2023
Medplus Health Services Ltd’s net profit jumped 166.07% since last year same period to ₹38.74Cr in the Q2 2024-2025. On a quarterly growth basis, Medplus Health Services Ltd has generated 169.78% jump in its net profits since last 3-months.
Read More about Earnings ResultsBearish
Neutral
Bullish
Medplus Health Services Ltd is currently in a Bullish trading position according to technical analysis indicators.
Medplus Health Services Ltd (MEDPLUS) share price today is ₹735.6
Medplus Health Services Ltd is listed on NSE
Medplus Health Services Ltd is listed on BSE
PE Ratio of Medplus Health Services Ltd is 87.95
PE ratio = Medplus Health Services Ltd Market price per share / Medplus Health Services Ltd Earnings per share
Today’s traded volume of Medplus Health Services Ltd(MEDPLUS) is 3.91L.
Today’s market capitalisation of Medplus Health Services Ltd(MEDPLUS) is ₹8832.14Cr.
Medplus Health Services Ltd(MEDPLUS | Price |
---|---|
52 Week High | ₹849 |
52 Week Low | ₹598.6 |
Medplus Health Services Ltd(MEDPLUS) share price is ₹735.6. It is down -13.36% from its 52 Week High price of ₹849
Medplus Health Services Ltd(MEDPLUS) share price is ₹735.6. It is up 22.89% from its 52 Week Low price of ₹598.6
Medplus Health Services Ltd(MEDPLUS | Returns |
---|---|
1 Day Returns | -3.2% |
1 Month Returns | 7.82% |
3 Month Returns | 16.43% |
1 Year Returns | -11.68% |